The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling
Abstract
Mammalian survival depends on metabolizing nutrients, storing energy, and combating infection. Complement activation in blood triggers energy‐depleting immune responses to fight infections. Here we identify surprising energy‐conserving roles for complement proteins C5a and C3a and their receptors, C5aR and C3aR, roles that are contraindicated in complement biology. Rats fed a high‐carbohydrate high‐fat diet developed obesity, visceral adiposity, adipose inflammation, glucose/insulin intolerance, and cardiovascular dysfunction that correlated with increased plasma C3a, adipose C5aR, and C3aR. These in vivo changes were dramatically attenuated by receptor‐selective antagonists of either C5aR (5 mg/kg/d p.o.) or C3aR (30 mg/kg/d p.o.), which both reduced proinflammatory adipokines and altered expression of inflammatory genes in adipose tissue. In vitro C5a and C3a (100 nM) exhibited novel insulin‐like effects on 3T3‐L1 adipocytes, promoting energy conservation by increasing glucose and fatty acid uptake while inhibiting cAMP signaling and lipolysis, and induced PGE 2 release from macrophages, effects all blocked by each respective antagonist (10 μM). These studies reveal important new links between complement signaling and metabolism, highlight new complement functions on adipocytes and in adipose tissue, demonstrate how aberrant immune responses may exacerbate obesity and metabolic dysfunction, and show that targeting C3aR or C5aR with antagonists is a new strategy for treating metabolic dysfunction.—Lim, J., Iyer, A., Suen, J. Y., Seow, V., Reid, R. C., Brown, L., Fairlie, D. P. C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J. 27, 822–831 (2013). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“C3aR, and its endogenous ligands has been implicated previously in obesity[101–105].”
From Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity (2026) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.1964 · Cited by 2,230
Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E., & Gewirtz, A. T. (2010) · Science · doi:10.1126/science.1179721 · Cited by 2,068
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Nutrient sensing and inflammation in metabolic diseases
Hotamisligil, G. S., & Erbay, E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2449 · Cited by 1,040
Research works printed but not linked: 28
- 10.1038/nrendo.2009.264 · DOI · Paper page
- 10.1038/nature05485 · DOI · Paper page
- 10.1210/jcem.87.7.8638 · doi:10.1210/jcem.87.7.8638 · Paper page
- 10.2337/db06-1491 · DOI · Paper page
- 10.1038/4641287a · DOI
- 10.1038/sj.bjp.0707332 · DOI · Paper page
- 10.1016/S0021-9258(18)42338-1 · DOI · Paper page
- 10.1152/ajpendo.00664.2006 · DOI
- 10.1007/s00125-005-0021-6 · DOI
- 10.3945/ajcn.2009.28101 · DOI
- 10.2337/diacare.23.6.779 · DOI
- 10.1074/jbc.M609734200 · DOI
- 10.1097/FJC.0b013e3181feb90a · DOI · Paper page
- 10.1021/jm9806594 · DOI · Paper page
- 10.1021/jm9800651 · DOI
- 10.4049/jimmunol.166.10.6341 · DOI · Paper page
- 10.1111/j.1476-5381.2010.00637.x · DOI
- 10.1371/journal.pone.0013809 · DOI
- 10.1016/j.ab.2010.05.012 · doi:10.1016/j.ab.2010.05.012
- Scully C. C., 2010, Selective hexapeptide agonists and antagonists for human complement C3a receptor, J. Med. Chem., 53, 4938, 10.1021/jm1003705 · doi:10.1021/jm1003705
- 10.1074/jbc.M609178200 · DOI
- 10.1177/1087057109341407 · DOI
- 10.1172/JCI200319451 · DOI · Paper page
- 10.1038/nm.1904 · DOI · Paper page
- 10.1073/pnas.78.2.732 · DOI
- 10.1038/ng.325 · DOI · Paper page
- 10.2337/db09-0323 · DOI · Paper page
- 10.1038/sj.bjp.0705819 · DOI
Cited by
Keeping It All Going—Complement Meets Metabolism
Kolev, M., & Kemper, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00001 · Cited by 812
Nutrients and Oxidative Stress: Friend or Foe?
Tan, B. L., Norhaizan, M. E., & Liew, W.-P.-P. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9719584 · Cited by 403
Adipsin Is an Adipokine that Improves β Cell Function in Diabetes
Lo, J. C., Ljubicic, S., Leibiger, B., Kern, M., Leibiger, I. B., Moede, T., Kelly, M. E., Chatterjee Bhowmick, D., Murano, I., Cohen, P., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.005 · Cited by 381
Pallais, J. P., Razzoli, M., Rodriguez, P., McGonigle, S., Daugherty, A., Hillman, H., Verteramo, L., Schrank, P. R., Parthiban, P., Chang, X., et al. (2026) · doi:10.64898/2026.04.18.719397 · Cited by 1
Metadata
- Authors
- Lim, J., Iyer, A., Suen, J. Y., Seow, V., Reid, R. C., Brown, L., & Fairlie, D. P.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2012-11
- Volume
- 27
- Issue
- 2
- Pages
- 822-831
- ISSN
- 0892-6638
- 1530-6860
- Cited by
- 129
- References
- 15
- Language
- en
- Funders
- Centre of Excellence for Environmental Decisions, Australian Research Council (DP1093245)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. https://app.cochat.ai/papers/10.1096/fj.12-220582
- The paper
- Lim, J., Iyer, A., Suen, J. Y., Seow, V., Reid, R. C., Brown, L., & Fairlie, D. P. (2013). C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. The FASEB Journal. https://doi.org/10.1096/fj.12-220582
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.